Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID

Overview

exercise activity during the COVID pandemic is appreciated to be conducted in home especially for chronic chest diseases as chronic obstructive pulmonary disease (COPD) to reduce the chance of viral contamination during the COVID-19 pandemic.

Full Title of Study: “Effect of Home Exercise Activity on Cortisol and Depression in COPD Patients During the Pandemic COVID-19″

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Outcomes Assessor)
  • Study Primary Completion Date: March 1, 2021

Detailed Description

40 COPD men will be divided to exercise group (20 patients) and control group (20 patients): the exercise group will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks. The control group will not be trained

Interventions

  • Behavioral: exercise group
    • the exercise group (20 patients) will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks.
  • Other: control group
    • the control group will not be trained

Arms, Groups and Cohorts

  • Experimental: Exercised group
    • the exercise group (20 patients) will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks.
  • Other: control group
    • The control group will not be trained

Clinical Trial Outcome Measures

Primary Measures

  • cortisol
    • Time Frame: It will be measured after eight weeks of training
    • it will be measured in plasma
  • hospital anxiety and depression scale
    • Time Frame: It will be measured after eight weeks of training
    • this a questionnaire that will assess anxiety and depression in COPD patients

Secondary Measures

  • pulmonary function test
    • Time Frame: It will be measured after eight weeks of training
    • it will be a measurement for lung volume and capacities
  • Interleukin-8
    • Time Frame: It will be measured after eight weeks of training
    • It is an inflammatory marker in plasma
  • body mass index
    • Time Frame: It will be measured after eight weeks of training
    • it will measure body mass changes
  • six minute walking test
    • Time Frame: It will be measured after eight weeks of training
    • it assess functional capacity
  • St. George’s respiratory questionnaire
    • Time Frame: It will be measured after eight weeks of training
    • It assess the effect of COPD on general quality of life

Participating in This Clinical Trial

Inclusion Criteria

  • stable COPD patients – patients who will have a training device as bicycle or treadmill in home Exclusion Criteria:
  • diabetic patients – renal patients. – liver diseases
  • Gender Eligibility: Male

    self-representation of gender identity

    Minimum Age: 50 Years

    Maximum Age: 70 Years

    Are Healthy Volunteers Accepted: No

    Investigator Details

    • Lead Sponsor
      • Cairo University
    • Provider of Information About this Clinical Study
      • Principal Investigator: Ali Mohamed Ali ismail, lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University – Cairo University
    • Overall Official(s)
      • Ali Ismail, lecturer, Principal Investigator, Cairo University
    • Overall Contact(s)
      • Ali Ismail, lecturer, 02 01005154209, allooka2012@gmail.com

    Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

    At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.